Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


P&G Endures 'Top-Line Pain' As Portfolio Streamlining Prioritizes Premium Products

This article was originally published in The Tan Sheet

Executive Summary

The firm reports slumps between 1% and 5% across each of its product categories, but also encourages analysts with reports of sometimes significant progress in its "transformation" initiatives in productivity, portfolio, organization and top-line growth.

You may also be interested in...

P&G Eyes Targeted Innovation, China Opportunities Amid Transformation

CFO Jon Moeller drives home that P&G is "operating in a more volatile environment than we ever have" as it continues shedding slow-growth brands. Hair care and grooming are high among the streamlined company's strategic priorities, as well as the US market and China.

In Brief: Revlon Sale?; P&G/Coty Fragrance Transfer; More

SEC filing affirms Revlon is exploring strategic alternatives; Procter & Gamble will transfer 10 fragrance licenses to Coty. More news in brief.

ICCR’s Growing Membership Ensures Diverse Cosmetics Regulatory Perspectives – PCPC

South Korea’s Ministry of Food and Drug Safety and Taiwan’s Food and Drug Administration will transition from ICCR observers to full members, joining regulatory authorities from the US, Europe, Japan, Canada and Brazil. PCPC’s Francine Lamoriello, EVP of global affairs, discusses.


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts